CSCO
63
2
KR
34
-3
DE
46
3
IFF
53
2
AMP
69
-3
V
60
-6
UA
45
-3
PDCO
35
-3
UNH
61
6
BEN
45
3
TDC
75
4
MTCH
37
7
TAP
58
-2
ACN
47
-2
VTR
49
-3
TEL
60
2
AMAT
36
5
PPL
54
2
IPG
49
10
MUR
43
3
CSCO
63
2
KR
34
-3
DE
46
3
IFF
53
2
AMP
69
-3
V
60
-6
UA
45
-3
PDCO
35
-3
UNH
61
6
BEN
45
3
TDC
75
4
MTCH
37
7
TAP
58
-2
ACN
47
-2
VTR
49
-3
TEL
60
2
AMAT
36
5
PPL
54
2
IPG
49
10
MUR
43
3
Financhill
Back

Tandem Diabetes Care Vs. Perspective Therapeutics Industry Stock Comparison

Sell
25

TNDM
Tandem Diabetes Care

Last Price:
30.72
Seasonality Move:
6.87%
Sell
30

CATX
Perspective Therapeutics

Last Price:
2.99
Seasonality Move:
34.33%
Sell
25
Tandem Diabetes Care (TNDM) is a Sell

Is Tandem Diabetes Care a Buy, Sell or Hold?

  • The current Tandem Diabetes Care [TNDM] share price is $30.15. The Score for TNDM is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • TNDM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $6.17. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TNDM Stock Price Chart

What is Tandem Diabetes Care's stock price today?

  • The Tandem Diabetes Care share price today is $30.15
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TNDM is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $6.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

TNDM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.18 Sell
Relative Strength Index (14 RSI): 42.11 Sell
Chaikin Money Flow: 1804569 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.55 - 34.13) Sell
Bollinger Bands (100): (34.3 - 44.56) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.47 Sell
Relative Strength Index (14 RSI): 14.63 Sell
Chaikin Money Flow: -723713 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.98 - 12.88) Sell
Bollinger Bands (100): (10.81 - 14.53) Sell

TNDM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.35 Buy
20-day SMA: 31.17 Sell
50-day SMA: 36.84 Sell
200-day SMA: 38.03 Sell
8-day EMA: 29.53 Buy
20-day EMA: 31.4 Sell
50-day EMA: 35.09 Sell
200-day EMA: 37.04 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.55 Sell
20-day SMA: 10.54 Sell
50-day SMA: 12.08 Sell
200-day SMA: 12.78 Sell
8-day EMA: 8.2 Sell
20-day EMA: 9.96 Sell
50-day EMA: 11.52 Sell
200-day EMA: 11.52 Sell

Tandem Diabetes Care Earnings Growth & TNDM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.51 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Tandem Diabetes Care Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):